A detailed history of Dimensional Fund Advisors LP transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 94,332 shares of IONS stock, worth $3.21 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
94,332
Previous 88,746 6.29%
Holding current value
$3.21 Million
Previous $4.23 Million 10.66%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$40.06 - $51.86 $223,775 - $289,689
5,586 Added 6.29%
94,332 $3.78 Million
Q2 2024

Aug 09, 2024

SELL
$36.45 - $47.7 $749,302 - $980,568
-20,557 Reduced 18.81%
88,746 $4.23 Million
Q1 2024

May 10, 2024

SELL
$42.03 - $53.55 $668,865 - $852,194
-15,914 Reduced 12.71%
109,303 $4.74 Million
Q4 2023

Feb 07, 2024

SELL
$43.39 - $51.63 $2.9 Million - $3.46 Million
-66,943 Reduced 34.84%
125,217 $6.33 Million
Q3 2023

Nov 09, 2023

BUY
$38.5 - $47.13 $363,671 - $445,189
9,446 Added 5.17%
192,160 $8.72 Million
Q2 2023

Aug 09, 2023

SELL
$34.73 - $43.33 $9.04 Million - $11.3 Million
-260,171 Reduced 58.74%
182,714 $7.5 Million
Q1 2023

May 12, 2023

SELL
$33.58 - $41.2 $522,471 - $641,030
-15,559 Reduced 3.39%
442,885 $15.8 Million
Q4 2022

Feb 09, 2023

SELL
$37.12 - $46.52 $3.8 Million - $4.77 Million
-102,484 Reduced 18.27%
458,444 $17.3 Million
Q3 2022

Nov 10, 2022

SELL
$36.54 - $48.66 $881,344 - $1.17 Million
-24,120 Reduced 4.12%
560,928 $24.8 Million
Q2 2022

Aug 12, 2022

BUY
$31.71 - $43.0 $7.34 Million - $9.96 Million
231,567 Added 65.51%
585,048 $21.7 Million
Q1 2022

May 13, 2022

SELL
$29.88 - $37.04 $992,314 - $1.23 Million
-33,210 Reduced 8.59%
353,481 $13.1 Million
Q4 2021

Feb 09, 2022

BUY
$25.61 - $35.1 $790,119 - $1.08 Million
30,852 Added 8.67%
386,691 $11.8 Million
Q3 2021

Nov 12, 2021

SELL
$33.54 - $40.55 $1.82 Million - $2.21 Million
-54,378 Reduced 13.26%
355,839 $11.9 Million
Q2 2021

Aug 12, 2021

SELL
$34.54 - $47.25 $1.63 Million - $2.22 Million
-47,064 Reduced 10.29%
410,217 $16.4 Million
Q1 2021

May 14, 2021

BUY
$42.51 - $63.78 $347,604 - $521,529
8,177 Added 1.82%
457,281 $20.6 Million
Q4 2020

Feb 25, 2021

BUY
$45.3 - $60.27 $20.3 Million - $27.1 Million
449,104 New
449,104 $25.4 Million

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $4.83B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.